Celldex (TCE2) Ratios
Celldex Ratios
DE:TCE2's free cash flow for Q2 2026 was $-60.59M. For the 2026 fiscal year, DE:TCE2's free cash flow was decreased by $-3.18M and operating cash flow was $-57.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.49 | 18.91 | 13.87 | 17.07 | 24.86 |
| Quick Ratio | 10.49 | 18.91 | 13.87 | 17.07 | 24.86 |
| Cash Ratio | 0.57 | 0.72 | 1.12 | 1.58 | 2.37 |
| Solvency Ratio | -4.58 | -3.41 | -3.80 | -4.12 | -2.68 |
| Operating Cash Flow Ratio | -4.14 | -3.99 | -3.45 | -5.57 | -3.69 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 478.85M | $ 701.82M | $ 395.24M | $ 291.16M | $ 385.66M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.11 | 1.06 | 1.08 | 1.08 | 1.06 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.06 | 0.05 | 0.09 | 0.07 |
| Net Debt to EBITDA | 0.10 | 0.16 | 0.23 | 0.24 | 0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | -2229.77% | -1614.53% | -3389.94% | -1046.23% |
| EBIT Margin | -17253.33% | -2248.76% | -2063.66% | -4543.74% | -1486.73% |
| EBITDA Margin | -17028.00% | -2203.50% | -2019.96% | -4420.87% | -1420.77% |
| Operating Profit Margin | -19160.00% | -2778.89% | -2245.27% | -4889.01% | -1531.78% |
| Pretax Profit Margin | -17253.33% | -2248.76% | -2054.76% | -4765.59% | -1520.92% |
| Net Profit Margin | -17253.33% | -2248.76% | -2054.76% | -4765.59% | -1516.04% |
| Continuous Operations Profit Margin | -17253.33% | -2248.76% | -2054.76% | -4765.59% | -1516.04% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 99.68% |
| EBT Per EBIT | 90.05% | 80.92% | 91.51% | 97.48% | 99.29% |
| Return on Assets (ROA) | -44.39% | -19.92% | -30.37% | -31.84% | -15.86% |
| Return on Equity (ROE) | -49.09% | -21.13% | -32.95% | -34.43% | -16.81% |
| Return on Capital Employed (ROCE) | -54.02% | -25.91% | -35.57% | -34.49% | -16.64% |
| Return on Invested Capital (ROIC) | -53.87% | -25.86% | -35.44% | -34.34% | -16.52% |
| Return on Tangible Assets | -46.56% | -20.63% | -32.26% | -34.50% | -16.89% |
| Earnings Yield | -14.33% | -9.70% | -7.36% | -5.37% | -4.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.74 | 10.03 | 1.52 | 6.79 | 27.04 |
| Payables Turnover | 0.00 | 50.09 | 33.78 | 24.63 | 43.41 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.19 | 0.85 | 1.04 | 0.30 | 0.71 |
| Asset Turnover | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Working Capital Turnover Ratio | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 |
| Cash Conversion Cycle | 490.32 | 29.11 | 229.31 | 38.92 | 5.09 |
| Days of Sales Outstanding | 490.32 | 36.40 | 240.12 | 53.74 | 13.50 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 7.29 | 10.81 | 14.82 | 8.41 |
| Operating Cycle | 490.32 | 36.40 | 240.12 | 53.74 | 13.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.17 | -2.45 | -2.21 | -2.21 | -1.42 |
| Free Cash Flow Per Share | -3.21 | -2.48 | -2.25 | -2.25 | -1.45 |
| Dividend Paid and CapEx Coverage Ratio | -77.72 | -82.22 | -59.02 | -56.75 | -48.77 |
| Capital Expenditure Coverage Ratio | -77.72 | -82.22 | -59.02 | -56.75 | -48.77 |
| Operating Cash Flow Coverage Ratio | -90.30 | -41.38 | -42.21 | -25.72 | -20.02 |
| Operating Cash Flow to Sales Ratio | -140.63 | -22.48 | -15.59 | -44.01 | -13.10 |
| Free Cash Flow Yield | -11.83% | -9.81% | -5.68% | -5.05% | -3.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.96 | -10.31 | -13.59 | -18.60 | -23.49 |
| Price-to-Sales (P/S) Ratio | 1204.09 | 231.80 | 279.16 | 886.63 | 356.16 |
| Price-to-Book (P/B) Ratio | 3.43 | 2.18 | 4.48 | 6.41 | 3.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.45 | -10.19 | -17.61 | -19.80 | -26.65 |
| Price-to-Operating Cash Flow Ratio | -8.56 | -10.31 | -17.91 | -20.15 | -27.20 |
| Price-to-Earnings Growth (PEG) Ratio | -0.12 | 0.64 | -0.63 | -0.40 | 1.25 |
| Enterprise Value Multiple | -6.97 | -10.36 | -13.59 | -19.81 | -24.52 |
| Enterprise Value | 1.78B | 1.60B | 1.89B | 2.06B | 1.62B |
| EV to EBITDA | -6.97 | -10.36 | -13.59 | -19.81 | -24.52 |
| EV to Sales | 1186.40 | 228.31 | 274.48 | 875.86 | 348.40 |
| EV to Free Cash Flow | -8.33 | -10.04 | -17.31 | -19.56 | -26.07 |
| EV to Operating Cash Flow | -8.44 | -10.16 | -17.61 | -19.90 | -26.60 |
| Tangible Book Value Per Share | 7.52 | 11.18 | 8.30 | 6.38 | 9.15 |
| Shareholders’ Equity Per Share | 7.93 | 11.60 | 8.86 | 6.96 | 9.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.02 | 0.11 | 0.14 | 0.05 | 0.11 |
| Net Income Per Share | -3.89 | -2.45 | -2.92 | -2.40 | -1.64 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.05 | 1.02 |
| Research & Development to Revenue | 163.40 | 23.30 | 17.15 | 34.90 | 12.21 |
| SG&A to Revenue | 29.20 | 5.49 | 4.49 | 11.54 | 4.41 |
| Stock-Based Compensation to Revenue | 24.14 | 4.88 | 3.47 | 0.00 | 1.92 |
| Income Quality | 0.82 | 1.00 | 0.76 | 0.92 | 0.86 |
Currency in USD
